Opko Health Inc (OPK) Stock Forecast & Price Target
Opko Health Inc · NASDAQ
$1.65+0.41 (+32.66%)
15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Opko Health Inc, 0 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $1.50 to $1.60, so the covering firms are broadly aligned. The average target of $1.55 sits 6% below the current $1.65. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.11 next quarter toward $-0.32 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Hold
Strong Buy00%
Buy00%
Hold3100%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Opko Health Inc.
As of Jul, 0 of 3 firms rate OPK a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
OPK EPS & revenue forecast
EPS · NEXT QUARTER
$-0.11
Range $-0.11 – $-0.11 · 1 analysts
Next period, 1 analysts expect Opko Health Inc to earn $-0.11 a share (range $-0.11 – $-0.11), versus — a year earlier. Full-year consensus is $-0.38, growing to $-0.32 the year after.
REVENUE · NEXT QUARTER
$134.7M
Range $127.7M – $138.5M · 1 analysts · -11% YoY
Revenue is expected to reach $134.7M (range $127.7M – $138.5M), -11.2% year-over-year. Full-year consensus is $536.9M, rising to $565.8M next year.
Top analysts covering Opko Health Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OPK.
#1
Yi Chen
HC Wainwright & Co. · Rank #238
Buy
$3.00+82.4% to target
Overall win rate
34%
+ Follow
#2
Edward Tenthoff
Piper Sandler · Rank #277
Buy
$3.00+82.4% to target
Overall win rate
29%
+ Follow
#3
Michael Petusky
Barrington Research · Rank #322
Hold
No targeton OPK
Overall win rate
29%
+ Follow
#4
Brian Cheng
JP Morgan
Hold
No targeton OPK
Coverage
—
+ Follow
#5
MR
Maury Raycroft
Jefferies
Hold
$1.60-2.7% to target
Coverage
—
+ Follow
OPK stock forecast FAQ
What is OPK's average 12-month price target?+
The 1 analysts with a live target average $1.55 for Opko Health Inc over the next 12 months, ranging from a $1.60 high to a $1.50 low.
Is OPK stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 3 analyst ratings, 0 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for OPK?+
The Street-high target is $1.60 (Jefferies), and the Street-low is $1.50. The average of all 1 active targets is $1.55.
How many Wall Street analysts cover OPK?+
3 analysts have an active rating on Opko Health Inc, and 1 firms carry a live 12-month price target.
Who is the most accurate analyst covering OPK?+
Among analysts who currently cover OPK, Yi Chen of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #238). Their current call is Buy with a $3.00 target.
What is Opko Health Inc's projected EPS for next quarter?+
The consensus estimate is $-0.11 per share (range $-0.11 – $-0.11) across 1 analysts. Full-year EPS is projected at $-0.38, rising to $-0.32 the following year.
How much revenue is Opko Health Inc expected to report next quarter?+
Consensus revenue is $134.7M (range $127.7M – $138.5M). Full-year revenue is projected at $536.9M, growing to $565.8M next year.
Have analysts been upgrading or downgrading OPK lately?+
As of Jul, 0 of 3 firms rate OPK a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OPK calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
